FDA Clearance Tracker · P120009-S004
NIT-OCCLUD PDA
Last checked: Nov 20, 2026Latest source record: Oct 17, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 17, 2024
Approved
Time to decision
644 days
Received Jan 12, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P120009-S004
- Device name
- NIT-OCCLUD PDA
- Applicant
- Pfm Medical, Inc.
- Applicant location
- Carlsbad, CA
- Received
- Jan 12, 2023
- Decided
- Oct 17, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P120009
Device type
- Device type
- OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for modifications to the Instructions for Use to reflect the findings of the final Post-Approval Study (PAS) Report submitted for the Nit-Occlud PDA PAS Study
Source documents
Other decisions for Pfm Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K242763 · Decided May 2, 2025 · 232 days after receipt
Device type: Set, Administration, Intravascular (FPA) · Hospital Medicine & Nursing
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.